LDS Hospital, Key in Pivotal Study of Artificial Heart, Starts Certification Program For CardioWest(TM) Temporary Total Artificial Heart.TUCSON, Ariz. -- On July 17 and 18, cardiothoracic cardiothoracic /car·dio·tho·rac·ic/ (-thah-ras´ik) pertaining to the heart and the thorax. car·di·o·tho·rac·ic n. Of or relating to the heart and the chest. surgeon Dr. Stephen Clayson, M.D., and his heart transplant heart transplant Procedure to remove a diseased heart and replace it with a healthy one from a legally dead donor. The first was performed in 1967 by Christiaan Barnard. team from LDS LDs See: Liquidated damages Hospital in Utah, are in Tucson receiving the first phase of certification training to implant the CardioWest temporary Total Artificial Heart (TAH-t). In the 1990s, LDS Hospital was one of five participating hospitals active in the pivotal clinical study of the CardioWest TAH-t. On March 17, 2004, during a public meeting with the FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. panel reviewing the device, cardiothoracic surgeon James Long, M.D., spoke in support of the TAH-t. Dr. Long was the founder and has been the director of the Utah Artificial Heart Program at LDS Hospital since 1993. On Oct. 15, 2004, the CardioWest TAH-t became the first and still only FDA approved temporary total artificial heart in the world. The first phase of training is occurring at University Medical Center in Tucson. The remaining three phases of TAH-t certification training take place at the hospital being certified. The third phase of certification is the proctored implant of the artificial heart by artificial heart pioneer Dr. Jack Copeland or another TAH-t veteran surgeon. LDS and all TAH-t certified hospitals have years, and often decades, of experience in human heart transplantation Heart Transplantation Definition Heart transplantation, also called cardiac transplantation, is the replacement of a patient's diseased or injured heart with a healthy donor heart. . In the pivotal clinical study, the TAH-t had a bridge to transplant success rate of 79 percent (New England Journal of Medicine The New England Journal of Medicine (New Engl J Med or NEJM) is an English-language peer-reviewed medical journal published by the Massachusetts Medical Society. It is one of the most popular and widely-read peer-reviewed general medical journals in the world. 2004; 351: 859-867), which is the highest success rate of any heart assist device in the world. LDS Hospital, recognized as Utah's premier healthcare facility in 2006 by the "Best of State" program, will join 21 of the world's finest transplant hospitals in the U.S., Canada and Europe that are certified to implant the TAH-t. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion